Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-28T13:00:26.124Z Has data issue: false hasContentIssue false
  • English
  • Français

Differences in Antimicrobial Susceptibility Among Hospitals in an Integrated Health System

Published online by Cambridge University Press:  02 January 2015

Teresa J. Lubowski ,
John L. Woon ,
Patricia Hogan  and
Ching-Chang Hwang
Teresa J. Lubowski*
Affiliation:
Pfizer Inc, New York, New York
John L. Woon
Affiliation:
Pfizer Inc, New York, New York
Patricia Hogan
Affiliation:
Pfizer Inc, New York, New York
Ching-Chang Hwang
Affiliation:
Pfizer Inc, New York, New York
*
Pfizer Inc, 235 East 42nd St, 150/37/3, New York, NY 10017
Get access Rights & Permissions [Opens in a new window]

Abstract

We evaluated the differences in antimicrobial susceptibility among hospitals in three different integrated healthcare systems. Each system provided antibiogram-susceptibility reports from representative hospitals. Reports were analyzed for statistically significant differences between hospitals in a given system for nine important organisms. We found numerous significant interhospital differences in antimicrobial-susceptibility patterns within health systems. For this reason, the practice of combining antibiotic-susceptibility data into a systemwide antibiogram should be discouraged.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 6 , June 2001 , pp. 379 - 382
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Bryce, EA, Smith, JA. Focused microbiological surveillance and gram-negative β-lactamase-mediated resistance in an intensive care unit. Infect Control Hosp Epidemiol 1995;16:331–334.Google Scholar
2.Fridkin, SK, Steward, CD, Edwards, JR, Pryor, ER, McGowan, JE JrArchibald, LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999;29:245–252.CrossRefGoogle ScholarPubMed
3.Richard, P, Le Floch, R, Chamoux, C, Pannier, M, Espaze, E, Richet, H. Pseudomonas aeruginosa outbreak in a burn unit role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994;170:377–383.CrossRefGoogle Scholar
4.Lorian, V, Bums, L. Predictive value of susceptibility tests for the outcome of antibacterial therapy. J Antimicrob Chemother 1990;25:175–181.CrossRefGoogle ScholarPubMed
5.Day, D, Lubowski, TJ, Yamaga, CC, Main, J, Van Vleet, J, Ambegaonkar, A. Computer-assisted evaluation of antibiotic regimen coverage and cost. Clin Ther 1999;21:1418–1425.CrossRefGoogle ScholarPubMed
6.Doern, GV, Brueggemann, AB, Perla, R, Daly, J, Halkias, D, Jones, RN, et al. Multicenter laboratory evaluation of the bioMerieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol 1997;35:2115–2119.CrossRefGoogle ScholarPubMed
7.Steward, CD, Stacker, SA, Swenson, JM, O'Hara, CM, Edwards, JR, Gaynes, RP, et al. Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae. J Clin Microbiol 1999;37:544–547.Google Scholar
8.Rittenhouse, SF, Miller, LA, Utrup, LJ, Poupard, JA. Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents. Diagn Microbiol Infect Dis 1996;26:1–6.Google Scholar
9.Doern, GV, Brueggemann, AB, Huynh, H, Wingert, E. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98. Emerg Infect Dis 1999;5:757–765.CrossRefGoogle Scholar
10.National Committee for Clinical Laboratory Standards. Analysis and presentation of cumulative antimicrobial susceptibility test data. Document M39-P. Wayne, PA: NCCLS; 2000.Google Scholar
11.Friedrich, LV, White, RL, Bosso, JA. Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes. Clin Infect Dis 1999;28:1017–1024.CrossRefGoogle ScholarPubMed